1
|
Vivès E, Brodin P and Lebleu B: A
truncated HIV-1 Tat protein basic domain rapidly translocates
through the plasma membrane and accumulates in the cell nucleus. J
Biol Chem. 272:16010–16017. 1997. View Article : Google Scholar : PubMed/NCBI
|
2
|
Frankel AD and Pabo CO: Cellular uptake of
the tat protein from human immunodeficiency virus. Cell.
55:1189–1193. 1988. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ho A, Schwarze SR, Mermelstein SJ, Waksman
G and Dowdy SF: Synthetic protein transduction domains: Enhanced
transduction potential in vitro and in vivo. Cancer Res.
61:474–477. 2001.PubMed/NCBI
|
4
|
Chen X, Lai J, Pan Q, Tang Z, Yu Y and
Zang G: The delivery of HBcAg via Tat-PTD enhances specific immune
response and inhibits Hepatitis B virus replication in transgenic
mice. Vaccine. 28:3913–3919. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Su JH, Wu A, Scotney E, Ma B, Monie A,
Hung CF and Wu TC: Immunotherapy for cervical cancer: Research
status and clinical potential. BioDrugs. 24:109–129. 2010.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Segal L, Wilby OK, Willoughby CR, Veenstra
S and Deschamps M: Evaluation of the intramuscular administration
of Cervarix™ vaccine on fertility, pre- and post-natal development
in rats. Reprod Toxicol. 31:111–120. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kawana K, Yoshikawa H, Taketani Y,
Yoshiike K and Kanda T: Common neutralization epitope in minor
capsid protein L2 of human papillomavirus types 16 and 6. J Virol.
73:6188–6190. 1999.PubMed/NCBI
|
8
|
Kawana K, Matsumoto K, Yoshikawa H,
Taketani Y, Kawana T, Yoshiike K and Kanda T: A surface
immunodeterminant of human papillomavirus type 16 minor capsid
protein L2. Virology. 245:353–359. 1998. View Article : Google Scholar : PubMed/NCBI
|
9
|
Hitzeroth II, Passmore JA, Shephard E,
Stewart D, Müller M, Williamson AL, Rybicki EP and Kast WM:
Immunogenicity of an HPV-16 L2 DNA vaccine. Vaccine. 27:6432–6434.
2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Rubio I, Bolchi A, Moretto N, Canali E,
Gissmann L, Tommasino M, Müller M and Ottonello S: Potent anti-HPV
immune responses induced by tandem repeats of the HPV16 L2 (20-38)
peptide displayed on bacterial thioredoxin. Vaccine. 27:1949–1956.
2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Kondo K, Ishii Y, Ochi H, Matsumoto T,
Yoshikawa H and Kanda T: Neutralization of HPV16, 18, 31, and 58
pseudovirions with antisera induced by immunizing rabbits with
synthetic peptides representing segments of the HPV16 minor capsid
protein L2 surface region. Virology. 358:266–272. 2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Palmer KE, Benko A, Doucette SA, Cameron
TI, Foster T, Hanley KM, McCormick AA, McCulloch M, Pogue GP, Smith
ML, et al: Protection of rabbits against cutaneous papillomavirus
infection using recombinant tobacco mosaic virus containing L2
capsid epitopes. Vaccine. 24:5516–5525. 2006. View Article : Google Scholar : PubMed/NCBI
|
13
|
Huh WK and Roden RB: The future of
vaccines for cervical cancer. Gynecol Oncol. 109(Suppl 2): S48–S56.
2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Gambhira R, Jagu S, Karanam B, Gravitt PE,
Culp TD, Christensen ND and Roden RB: Protection of rabbits against
challenge with rabbit papillomaviruses by immunization with the N
terminus of human papillomavirus type 16 minor capsid antigen L2. J
Virol. 81:11585–11592. 2007. View Article : Google Scholar : PubMed/NCBI
|
15
|
Green M and Loewenstein PM: Autonomous
functional domains of chemically synthesized human immunodeficiency
virus tat trans-activator protein. Cell. 55:1179–1188. 1988.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Gupta B and Torchilin VP: Transactivating
transcriptional activator-mediated drug delivery. Expert Opin Drug
Deliv. 3:177–190. 2006. View Article : Google Scholar : PubMed/NCBI
|
17
|
Dietz GP and Bähr M: Delivery of bioactive
molecules into the cell: The Trojan horse approach. Mol Cell
Neurosci. 27:85–131. 2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Schwarze SR, Ho A, Vocero-Akbani A and
Dowdy SF: In vivo protein transduction: Delivery of a biologically
active protein into the mouse. Science. 285:1569–1572. 1999.
View Article : Google Scholar : PubMed/NCBI
|